Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | nr 4 | 24-40
Tytuł artykułu

Quality and Safety of Odorant Substances Present in Cosmetics : Selected Problems

Warianty tytułu
Jakość i bezpieczeństwo substancji zapachowych zawartych w kosmetykach : przegląd aktualnych zagadnień
Języki publikacji
Obecne przepisy o kosmetykach (Dyrektywa 76/768/ CEE, jej aktualizacja 2003/15/CE 2005/42/CE, 2007/67/CE, 2008/42/CE, 2009/36/CE i późniejsze zmiany) ograniczają użycie w produktach kosmetycznych substancji chemicznych klasyfikowanych jako rakotwórcze, mutagenne lub toksyczne dla ludzkiego układu rozrodczego (CMR). W czasie badań i produkcji w dziedzinie kosmetyki należy również powołać się na podstawowe systemy jakościowe. Powyższe przepisy prawne i jakościowe nie wykluczają jednak komercjalizacji substancji zapachowych, w niektórych przypadkach uważanych za równie niebezpieczne dla układu nerwowego, jak również dla układu hormonalnego czy oddechowego. Ponadto istnieje brak informacji na temat ewentualnych zanieczyszczeń środowiska wytwarzanych przez wyżej wymienione substancje. Niestety, wiele z badanych związków zapachowych uznanych za potencjalnie szkodliwe dla człowieka i środowiska jest obecne w ponad 3100 rodzajach perfum aktualnie dostępnych w sprzedaży. Władze, firmy i przedsiębiorcy, przede wszystkim ci związani z przemysłem kosmetycznym, powinni zwrócić uwagę na potrzebę lepszej ochrony zdrowia konsumentów. (abstrakt oryginalny)
Current regulations on cosmetics (Directive 76/768/CEE with the relevant updates 2003/15/CE, 2005/42/CE, 2007/67/CE, 2008/42/CE, 2009/36/CE and further amendments) restrict the use in cosmetic products of chemical substances classified as Carcinogenic, Mutagenic, or toxic to the human Reproductive system (CMR). The major quality systems ap-plicable to research and production in the field of cosmetics are briefly recalled. The above legal provisions, however, do not rule out the addition of odorants that are considered to be, e.g., equally hazardous to the nervous, endocrine, and respiratory system. In addition, no information is given about the possible environmental pollution produced by the above-mentioned substances. A number of odorants are surveyed, which are contained in more than 3100 fragrances commercially available at present and deemed to potentially cause adverse effects to man and the environment. The need for better protection of the consumer from health risks by the relevant authorities, firms, and traders is discussed. (original abstract)
Opis fizyczny
  • La Sapienza University, Rome
  • Instituto Superiore di Sanita
  • [1] IFRA (International Fragrance Association), Guidelines for safe usage of fragrant chemicals and essential oils in perfumes and skincare, Index of IFRA Standards (2010),
  • [2] Buckley D.A., Rycroft R.J.G., White I.R., Mc Fadden J.P. (Eds.) (2003) The frequency of fragrance allergy in patch-tested patients increases with their age, Brit. J. Dermatology, 149, 986-989.
  • [3] Jansson T., Loden L. (Eds.) (2001) Strategy to decrease the risk of adverse effects of fragrance ingredients in cosmetic products, Am. J. Contact Dermat., 12, 166-169.
  • [4] Sarantis H., Naidenko O.V., Gray S., Houlihan M., Malkan S. (Eds.) (2010) Not so sexy, The health risks of secret chemicals in fragrance, Canadian Edition Edits by Environmental Defence, Canada, 1-44.
  • [5] OECD Series on Principles of Good Laboratory Practice and Compliance Monotoring, Number 1, OECD, Principles on Good Laboratory Practice (as revised in 1997), ENV/MC/CHEM (98) 17, OECD, Paris, (1998).
  • [6] Directive 2009/36/CE, April 16th, 2009, Off. J. Eur. Comm., L 98, 17/04/2009, 1-31.
  • [7] Directive 2008/42/(CE), April 3rd, 2008, Off. J. Eur. Comm., n. L 93, 04/04/2008, 13-23.
  • [8] Directive 2007/67/CE, November 22nd, 2007, Off. J. Eur. Comm., n. L 305, 23/11/2007, 1-22.
  • [9] Directive 2005/42/CE, June 20th, 2005, Off. J. Eur. Comm., n. L 158, 21/06/2005, 17-19.
  • [10] Directive 2003/83/CE, September 24th, 2003, Off. J. Eur. Comm., n. L 238, 25/09/2003, pp. 23-27.
  • [11] Directive 2003/15/CE, February 27th, 2003, Off. J. Eur. Comm., n. L 66, 11/03/2003, 26-35.
  • [12] Directive 88/388/EEC, June 22th, 1988, Off. J. Eur. Comm., n. L 184 (Annex II), 15/07/1988, pp. 1-61.
  • [13] Directive 76/768/EEC, July 27th, 1976, Off. J. Eur. Comm., n. L 262, 27/09/1076, pp. 169-200.
  • [14] Dietrich D.R., Hitzfeld B.C. (2004) Bioaccumulation and ecotoxicity of synthetic musks in the aquatic environment, in: Rimkus G.G. (Ed.) Synthetic Musk Fragrances in the Environment, Springer-Verlag, Berlin, pp. 233-244.
  • [15] Peters R.J.B. (Ed.) Phthalates and artificial musks in perfumes, TNO Report, Netherlands (2005), pp. 1-35.
  • [16] WHO, Concise International Chemical Assessment Document 52: Diethyl phthalate, WHO, Geneva (2003), ISBN 92-4-153052-9, pp. 1-32.
  • [17] WWF, Contamination: the Next Generation - Results of the Family Chemical Contamination Survey, WWF-UK Chemicals and Health campaign report in conjunction with the Cooperative Bank, WWF, October, (2004) p. 1-45 (,uk/filelibrary/pdf/family biomonitoring.pdf).
  • [18] OSPAR (Oslo and Paris Convention for the Protection of the Marine Environment of the North-East Atlantic), Musk Xylene and Other Musks, OSPAR Commission (2004), pp. 1-45, ISBN 1-904426-36-0 (www,
  • [19] Greenpeace International, Perfume. An Investigation of Chemicals in 36 Eaux de Toilette and Eaux de Parfüm, February 10th (2005), pp. 1-15.
  • [20] Eisenhardt S., Runnebauma B., Bauerb K., Gerhard I. (Eds.) (2001 Nitromusk compounds in women with gynecological and endocrine dysfunction, Environ. Res., 87, pp. 123-130.
  • [21] SCCNFP, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning Hexahydro-hexamethyl-cyclopenta(gamma)-2-benzopyran (HHCB), 21st plenary meeting of September 17th (2002), SCCNFP/0609/02, pp. 1-8.
  • [22] SCCNFP, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers concerning 6-acetyl-1,1,2,4,4,7-hexamethyltetraline (AHTN), 21st plenary meeting of September 17th, (2002), SCCNFP/0609/02, pp. 1-9.
  • [23] Hutter H.P., Wallner P., Moshammer H., Hartl W., Sattelberger R., Lorbeer G., and Kundi M. (Eds.), Synthetic musks in blood of healthy young adults: Relationship to cosmetics use, Sci. Total Environ., 407, (2009), pp. 4821-4825.
  • [24] Adibi J.J., Perera F.P., Jedrychowski W., Camann D.E., Barr D., Jacek R., and Whyatt R.M., (Eds.), Prenatal exposures to phthalates among women in New York City and Krakow, Environ. Health Perspect, 111, (2003), pp. 1719-1722.
  • [25] SCCNFP, The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Opinion concerning diethyl phthalate, 26th plenary meeting, December 9th (2003), SCCNFP/0767/03, pp. 1-7.
  • [26] Les phtalates en cosmetology, Vigilances, Bull. Agence Française Séc. Sanit. Prod. Santé, 28, (2005), pp. 1-4.
  • [27] Peters R.J.B. (Eds.), Chemical Additives in Consumers Products, TNO Report R2005/066, Netherlands, (2005), VI + 24 pp.
  • [28] Peters R.J.B. (Eds.), Hazardous Chemicals in Precipitation, TNO Report R2003/198, Netherlands, (2003), pp. 1-50.
  • [29] Rutel R.A., Petrovic L. (Eds.) (2009) Endocrine disrupting chemicals in indoor and outdoor air, Atmos. Environ., 43, pp. 170-181.
  • [30] US Department of Health and Human Service, Human Reproduction, National Toxicology Program 2000, NTP-CERHR Expert Panel Report on DEP, DEHP, BBP, DINP, DIDP (2000), pp. 188.
  • [31] Health Canada, Medical Devices Bureau, DEHP in Medical Devices. An Exposure and Toxicity Assesment, (2002), pp. 1-6.
  • [32] Peters R.J.B., Man-made Chemicals in Human Blood, TNO Report R2004/493, Netherlands, (2004), pp. 1-60.
  • [33] Testai E. (Ed.) (2004) La valutazione tossicologica delle sostanze chimiche: l'approccio della Unione Europea, Notiz. ISS, 17, pp. 11-16.
  • [34] IFRA (International Fragrance Association), IFRA position statement on diethyl phthalate (DEP), (2009), 1 p., (available at
  • [35] Cosmetic Ingredient Review (CIR) Panel, (2009a): Cosmetic Ingredients Found Safe as Used, (available at
  • [36] Cosmetic Ingredient Review (CIR) Panel, (2009b): Publications list through December 2009, (available at
  • [37] Silva M.J., Barr D.B., Reidy J.A., Malek N.A., Hodge C.C, Caudill S.P. (Eds.), Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000, Environ. Health Perspect., (2004), 112, pp. 331-338.
  • [38] U.S. Environmental Protection Agency (USEPA), (2009b): EPA Announces Actions to Address Chemicals of Concern, Including Phthalates: Agency continues efforts to work for comprehensive reform of toxic substance laws, Press Release, 12/30/2009 (available at C60dc0f65c688525769c0068b219).
  • [39] SCCP/1016/06, Opinion on phthalates in cosmetic products, 16d- EFSA [a. Scientific opinion on DINP(July, 2005); b. Scientific opinion on DIDP(July, 2005); d. Scientific opinion on DEHP(June, 2005); e. Scientific opinion on DBP(June, 2005); f. Scientific opinion on BBP(June, 2005)], pp. 1-19.
  • [40] Sautebin L. (Ed.), Sicurezza d'uso del DEP nei prodotti cosmetici, Cosmovigilanza, UNIPRO, 2 Dicembre (2008), pp. 1.
  • [41] Dorato, S. (Ed.), Un anno di attività normativa sui cosmetici nell'Unione Europea, Convegno Tecnico UNIPRO, Bologna, April 3rd (2009), pp. 1-37.
  • [42] SCCNFP/0690/03, Notes for Guidance for testing of Cosmetic Ingredients for their Safety Evaluation, SCCNFP 25th Plenary Meeting of 20 October (2003), IX + 94 pp.
  • [43] Betton C.I. (Ed.), Global Regulatory Issues for the Cosmetics Industry, William Andrew, USA, (2007), 155 pp.
  • [44] Pochet A., Gerbod P. (2004) Etiquetage des produits cosmétiques, Vigilances, Bull. Agence Française Séc. Sanit.Prod. Santé, 23, 1-4.
  • [45] U.S. Environmental Protection Agency (USEPA), Code of Federal Regulation Title 40: Protection of Environment, Appendix A to Part 423-126 Priority Pollutants, 2002, pp. 1-49.
  • [46] U.S. Environmental Protection Agency (USEPA), Guidelines for Carcinogen Risk Assessment, April (2005), (available at
  • [47] Wallace L.A. (2001) Human exposure to Volatile Organic Pollutants: Implications for Indoor Air Studies, Annual Review of Energy and the Environment, 26, pp. 269-301.
  • [48] U.S. Environmental Protection Agency (USEPA), 2009a: Inventory Update Reporting (IUR) Data for 2006, (2009), (available at
  • [49] Sell, C.S. (Ed.), The chemistry of Fragrances, Royal Society of Chemistry, Cambridge (2006), XVI + 321 pp.
  • [50] Annex VI of Directive 67/548/EEC through the 31 st ATP, RTEC, Food and Chemical Toxicology, Benzaldehyde, Pergamon Press Inc., N.Y., vol. 20-46, (2008), pp. 1-1034.
  • [51] NTP, Tech. Rep. Ser. 431, Toxicology and Carcinogenesis Studies of Benzyl acetate, CAS Number: 140-11-4, Sept. (1993), pp. 1 -285p.
  • [52] FDA (Food Additives Permitted for Direct Addition to Food for Human Consumption), part 172, Benzyl acetate (CAS n. 140-11-4), Subpart F - Flavoring Agents and Related Substances, 3 August (2010), pp. 1-3.
  • [53] JECFA (Joint FАО/WHO Expert Committee on Food Additives), WHO Food Additives : Series 48, Fifty-seventh Meeting of the Joint FАО/WHO Expert Committee on Food Additives, World Health Organization, Geneva, (2002), pp. 227-271.
  • [54] Kemp A., Berke G. (Eds.) (1973) Inhibition of lymphocyte-mediated cytolysis by the local anesthetics benzyl and salicyl alcohol, Eur. J. Immunoj., 3, pp. 674-677.
  • [55] SCF, Opinion of the Scientific Committee on Food on Benzyl alcohol, SCF/CS/ADD/FLAV/78 Final, 17 Sept. (2002), pp. 1-15.
  • [56] Robertson J.S., Hussain M. (Eds.) (1969) Metabolism of camphors and related compounds. Biochem. J., 113, pp. 57-65.
  • [57] Berar M., Mai Т., Lewis D. (Eds.) (2003) A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee, J. Rheumatol., 30, pp. 523-528.
  • [58] Cohen M., Wolfe R.R.R., Kroon L.A., McDermott J.H., Newton G.D., Oszko M.A., Popovich N.G., Remington T.L., Rollins C.J., Shimp L.A., Tietze K.J. (Eds.), Handbook of Non prescription Drugs (15th edition), American Pharmaceutical Association, Washington DC (2006), pp. 1-1235.
  • [59] United States Food and Drug Administration, Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph., Fed. Reg., 48, (1983), pp. 5852-5869.
  • [60] European Commission, EU Public Consultation Updated Regulation of UV-Filters, Directorate-General Enterprise and Industry, Brussels, (2009), pp. 1-15.
  • [61] Omodeo-Sale F., Gramigna D., Campaniello R. (Eds.) (1997) Lipid peroxidation and antioxidant systems in rat brain: effect of chronic alcohol consumption, Neurochem. Res., 22, pp. 577-582.
  • [62] Miles M.F. (Ed.) (1995) Alcohol's effects on gene expression, J. Alcohol Health Res World, 19, pp. 237-243.
  • [63] Fridovich, I. (Ed.) (1978) The biology of oxygen radicals, Science, 201, pp. 875-880.
  • [64] Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Health and Environmental Effects Profile for Ethyl Acetate, Cincinnati, OH for the Office of Solid Waste and Emergency Response, Washington, DC, (1987), pp. 1-4.
  • [65] Smyth H.F., Carpenter C.P., Weil C.S., Pozzani U.C., and Striegel J.A. (Eds.), Range-finding toxicity data: List VI., Am. Ind. Hyg. Assoc., 23, (1962), pp. 95-107.
  • [66] U.S. EPA., Rat Oral Subchronic Study with Ethyl Acetate, Office of Solid Waste, Washington, DC, (1986), pp. 1-4.
  • [67] Neunschwander, U., Guignard, F., and Hermans, I. (Eds.), Mechanism of the aerobic oxidation of alpha-pinene, Chem. Sus. Chem., 3, (2010), pp. 75-84.
  • [68] SCCP /0935/05, Opinion on Coumarin, 8th plenary meeting, 20 June 2006, pp. 1-17.
  • [69] Felter S.P., Vassallo J.D., Carlton B.D., and Daston G.P. (Eds.), A safety assessment of coumarin taking into account species-specificity of toxicokinetics, Food Chem. Toxicol., 44, (2006), pp. 462-475.
  • [70] Lake B. (Ed.), Coumarin metabolism, toxicity, and carcinogenicity: relevance for human risk Assessment, Food Chem. Toxicol., 37, (1999), pp. 423-453.
  • [71] Floch F., Mauger F., and Desmurs J. R. (Eds.), Coumarin in plants and fruits: implications in perfumery, Perf. Flav., 27, (2002), pp. 32-37.
  • [72] Vocanson M., Goujon C., Chabeau G., Castelain M., Valeyrie M., Floch F., Maliverney C., Gard A., and Nicolas J.F. (Eds.), The skin allergenic properties of chemicals may depend on contaminants, Int. Arch. Allergy Immunol., 401, (2006), pp. 231-238.
  • [73] Saito M., Kumano H., Yoshiuchi K., Kobuko N., Ohashi K., Yamamoto Y., Shinohara N., Yanagisawa Y., Sakabe K., Miyata M., Ishikawa S., Kuboki T. (Eds.) (2005) Symptom profile of multiple chemical sensitivity in actual live, Psychosom. Med., 67 318-325.
  • [74] Steinemann A. (Ed.) (2009) Fragranced Consumer Products and Undisclosed Ingredients, Environmental Impact Assessment Review, 29 (1), pp. 32-38.
  • [75] EU Scientific Committee on Cosmetic Products and Non-Food Products, Fragrance Allergy in Consumers. A review of the problem, Brussels EU Commission, DG SANCO, SCCNFP/0017/98 final, 8th December 1999, pp. 1-14, (available at comm/food/fs/sc/sccp/out98_en.pdf).
  • [76] Rastogi S.C. (Ed.), Analysis of fragrances in cosmetics by gas chromatography-mass spectrometry, J. High Resolution Chromatogr., 18, (1995), pp. 653-658.
  • [77] Johansen J.D., Rastogi S.C., Menne T. (Eds.) (1996) Contact allergy to popular perfumes; assessed by patch, use tests and chemical analysis, Br. J. Dermatol., 135,419-422.
  • [78] Rastogi S.C., Johansen J.D., Frosch F., Menne' Т., Bruze M.T., Lepoittevin J.P., Dreier В., Andersen K.E., and White I.R. (Eds.), Deodorants on the European market: quantitative chemical analysis of 21 fragrances, Contact Dermat., 38, (1998), pp. 29-35.
  • [79] Rastogi S.C., Heydron S., Johansen J.D., and Basketter D.A., Fragrance chemicals in domestic and occupational products. Contact Dermat., 45, (2001), pp. 221-225.
  • [80] Rastogi S.C. (Ed.), Survey of Chemical Compounds in Consumer Products; Contents of selected fragrance materials in cleaning products and other consumer products, Survey, 8, National Environmental Research Institute, Denmark, (2002), pp. 1-29.
  • [81] Gilbert J. (Ed.), Applications of Mass Spectrometry in Food Science, Elsevier Applied Science Publishers, London and New York, (1987), pp. 1-440.
  • [82] Ellendt K., Hempel G., and Köbler H. (Eds.), Analysis of sensitiving fragrances by GC-MS, SÖFW-Journal, 127, (2001), pp. 29-34.
  • [83] Chaintreau A., Joulain D., Marin С., Schmidt C.O., and Vey M. (Eds.), GC-MS quantitation of fragrance compounds suspected to cause skin reactions, J. Agric.Food Chem., 51, (2003), pp. 6398-6403.
  • [84] Peck A.M., Linebaugh E.K., Hornbuckle K.C. (Eds.) (2006) Synthetic Musk Fragrances in Lake Erie and Lake Ontario Sediment Cores, Environ. Sci. Technol., 40, pp. 5629-5635.
  • [85] U.S. Environmental Protection Agency (USEPA), 2007b: Development of Analytical Methods for the Identification of Synthetic Musk Compounds in Environmental Samples, (available at
  • [86] Kinani S., Bouchonnet S., and Magne A. (Eds.), Détection et dosage de composés allergénes dans des compositions de parfumerie par couplage Chromatographie en phase gazeuse -spectrométrie de masse, Spectra Analyse, 248, (2006), pp. 26-36.
  • [87] Liang Y-Z., Xie P., and Chan K. (Eds.), Quality control of herbal medicines, J. Chromatogr. B, 812, (2004), pp. 53-70.
  • [88] Marriott P.J., Schellie R., Cornwell C., (Eds.) (2001), Gas Chromatographic technologies for the analysis of essential oils. J. Chromatogr. A, 936, pp. 1-22.
  • [89] Berger R.G. (Ed.) (2007) Flavors and Fragrances; Chemistry, Bioprocessing and Sustainability, Springer Verlag. XVI+115 pp.
  • [90] Beens J., Brinkman U.A.T. (Eds.) (2003) Comprehensive two-dimensional gas chromatography: a powerful and versatile analytical tool, J. Chromatogr. A, 1000, pp. 69-108.
  • [91] Adahchour M., Jover E., Beens J., Vreuls R.J.J., and Brinkman U.A.T. (Eds.), Twin comprehensive two-dimensional gas Chromatographie system: concept and applications, J. Chromatogr. A, 1101, (2005a), pp. 128-134.
  • [92] Adahchour M., Brandt M., Baier H-U., Vreuls R.J.J., Batenburg A.M., and Brinkman U.A.T. (Eds.), Comprehensive two-dimensional gas chromatography coupled to a rapid-scanning quadrupole mass spectrometer: principles and applications, J. Chromatogr. A, 1067, (2005b), pp. 245-254.
  • [93] Adahchour M., Beens J., Vréuls R.J.J., Brinkman U.A.T. (Eds.) (2006) Recent develop/ments in comprehensive two-dimensional gas chromatography (GCxGC) IV. Further applications, conclusions and perspectives, Trends Anal. Chem., 25, pp. 821-840.
  • [94] Mondello L., Casilli A., Tranchida P.Q., Dugo G., Dugo P. (Eds.) (2005) Comprehensive two-dimensional gas chromatography in combination with rapid scanning quadrupole mass spectrometry in perfume analysis J. Chromatogr. A, 1067, pp. 235-243.
  • [95] Shellie R.A., Marriott P.J., Huie C.W. (Eds.) (2003) Comprehensive two-dimensional gas chromatography (GCxGC) and GCxGC-quadrupole MS analysis of Asian and American ginseng, J. Sep. Sci., 26, pp. 1185-1192.
  • [96] Cordero C., Bicchi C., Joulain D., Rubiolo, P. (Eds.) (2007) Identification, quantitation and method validation for the analysis of suspected allergens in fragrances by comprehensive two-dimensional gas chromatography coupled with quadrupole mass spectrometry and with flame ionization detection, J. Chromatogr. A, 1150, pp. 37-49.
  • [97] Kallio M.K. (2008) Comprehensive Two-Dimensional Gas Chromatography: Instrumental and Methodological Development, Academic Dissertation, Helsinki, pp. 1-94.
  • [98] Eurachem, Guide (1998) The fitness for purpose of analytical methods. A laboratory guide to method validation and related topics, 1st Ed., LGC, UK, pp. 1-75.
  • [99] CITAC/Eurachem (2002) Guide to Quality in Analytical Chemistry; An Aid to Accreditation, pp. 1-57.
  • [100] Ellison S.L.R., Rosslein M., Williams A. (Eds.), (2000) Quantifying Uncertainty in Analytical Measurement, Eurachem/CITAC Guide CG 4, 2nd Ed., UK, pp. 1-126.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.